| 1 | Lymphomatoid Papulosis | 49.7% |
| 2 | Sezary Syndrome | 49.7% |
| 3 | Enteropathy-Associated T-Cell Lymphoma | 37% |
| 4 | Lymphoma, Follicular | 30.3% |
| 5 | Mantle cell lymphoma | 30.3% |
| 6 | Hodgkin Disease | 26.4% |
| 7 | Composite Lymphoma | 25.9% |
| 8 | Tumor Lysis Syndrome | 19.1% |
| 9 | Lymphoma, Extranodal NK-T-Cell | 18.3% |
| 10 | Lymphoma, AIDS-Related | 18.1% |
| 11 | Primary Effusion Lymphoma | 18.1% |
| 12 | Lymphomatoid Granulomatosis | 17.7% |
| 13 | Autoimmune Lymphoproliferative Syndrome | 16% |
| 14 | Infectious Mononucleosis | 14.7% |
| 15 | Plasmacytoma | 13.9% |
| 16 | Burkitt Lymphoma | 13.7% |
| 17 | Primary amyloidosis | 12.9% |
| 18 | Histiocytic Disorders, Malignant | 12.5% |
| 19 | Plasmablastic lymphoma | 12% |
| 20 | Heavy Chain Disease | 12% |
| 21 | Sarcoidosis | 11.9% |
| 22 | Agammaglobulinemia | 11.5% |
| 23 | Lymphocele | 11% |
| 24 | Waldenstrom Macroglobulinemia | 10.9% |
| 25 | Multiple Myeloma | 10.9% |
| 26 | Lymphangioleiomyomatosis | 10.6% |
| 27 | Leukemia, T-Cell | 10.3% |
| 28 | Leukemia, B-Cell | 10.3% |
| 29 | leukemia | 10.3% |
| 30 | Neoplasms, Germ Cell and Embryonal | 10.3% |
| 31 | Neoplasms, Glandular and Epithelial | 10.3% |
| 32 | Germ Cell Cancer | 10.3% |
| 33 | Adenitis | 10% |
| 34 | Histiocytosis | 10% |
| 35 | Lymphadenitis | 10% |
| 36 | Lymphangitis | 10% |
| 37 | Lymphedema | 10% |
| 38 | Splenic Diseases | 10% |
| 39 | Thymus Hyperplasia | 10% |
| 40 | Pseudolymphoma | 10% |
| 41 | Lymphadenopathy | 10% |
| 42 | Leukemia, Plasma Cell | 9.8% |
| 43 | Granuloma | 9.7% |
| 44 | Thymus Neoplasms | 9.5% |
| 45 | Paraproteinemias | 9.4% |
| 46 | Neuroectodermal Tumors | 8.7% |
| 47 | Transfusion Reaction | 8.3% |
| 48 | Hypotensive Transfusion Reaction | 8.3% |
| 49 | Lymphatic Abnormalities | 8.2% |
| 50 | Hypergammaglobulinemia | 8% |
| 51 | Thymoma | 7.7% |
| 52 | Neoplasms, Neuroepithelial | 7.6% |
| 53 | Gliomatosis cerebri | 7.6% |
| 54 | Splenic Neoplasms | 6.9% |
| 55 | Hamartoma | 6.9% |
| 56 | Neoplasms, Hormone-Dependent | 6.9% |
| 57 | Neoplasms, Multiple Primary | 6.9% |
| 58 | Paraneoplastic Syndromes | 6.9% |
| 59 | Precancerous Conditions | 6.9% |
| 60 | Neoplasms, Second Primary | 6.9% |
| 61 | Monoclonal Gammopathy of Undetermined Significance | 6.9% |
| 62 | Lymphangiectasis, Intestinal | 6.9% |
| 63 | Autoimmune Diseases | 6.8% |
| 64 | Hypersensitivity | 6.8% |
| 65 | Immunologic Deficiency Syndromes | 6.8% |
| 66 | Immune reconstitution syndrome | 6.8% |
| 67 | Immune Reconstitution Inflammatory Syndrome | 6.8% |
| 68 | Mucocutaneous Lymph Node Syndrome | 6.7% |
| 69 | Carcinosarcoma | 6.7% |
| 70 | Hemangiosarcoma | 6.7% |
| 71 | lymphangiosarcoma | 6.7% |
| 72 | Meningioma | 6.5% |
| 73 | Malignant histiocytosis | 6.5% |
| 74 | Histiocytic sarcoma | 6.5% |
| 75 | Trophoblastic Neoplasms | 6% |
| 76 | melanoma | 6% |
| 77 | Leukemia, Experimental | 6% |
| 78 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 79 | Leukemia, Large Granular Lymphocytic | 5.8% |
| 80 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 81 | Cyst | 5.6% |
| 82 | Neoplastic Processes | 5.6% |
| 83 | Neoplastic Syndromes, Hereditary | 5.6% |
| 84 | Pregnancy Complications, Neoplastic | 5.6% |
| 85 | Hematologic Neoplasms | 5.5% |
| 86 | Neoplasms, Experimental | 5.5% |
| 87 | Carcinoma 256, Walker | 5.5% |
| 88 | Adenoma | 5.4% |
| 89 | Ameloblastoma | 5.4% |
| 90 | Angiokeratoma | 5.4% |
| 91 | Carcinoma | 5.4% |
| 92 | Chordoma | 5.4% |
| 93 | Hemangioma | 5.4% |
| 94 | hemangiopericytoma | 5.4% |
| 95 | Lymphangioma | 5.4% |
| 96 | Mesenchymoma | 5.4% |
| 97 | Nevus | 5.4% |
| 98 | Teratoma | 5.4% |
| 99 | Hepatoblastoma | 5.4% |
| 100 | Mixed Tumor, Mullerian | 5.4% |
| 101 | Germinoma | 5.4% |
| 102 | Teratocarcinoma | 5.4% |
| 103 | Angiofibroma | 5.4% |
| 104 | Sarcoma | 5.4% |
| 105 | Epithelioma | 5.4% |
| 106 | Carcinoma, Ehrlich Tumor | 5.2% |
| 107 | Dermoid Cyst | 5.2% |
| 108 | Carcinoma, Lewis Lung | 5.2% |
| 109 | Leukemia, Radiation-Induced | 5.2% |
| 110 | Elephantiasis | 5.1% |
| 111 | Hypersplenism | 5.1% |
| 112 | Elephantiasis Nostras Verrucosa | 5.1% |
| 113 | Sarcoidosis, Pulmonary | 5% |
| 114 | Basal cell carcinoma | 4.8% |
| 115 | Carcinoma, Papillary | 4.8% |
| 116 | Squamous cell carcinoma | 4.8% |
| 117 | Chondrosarcoma | 4.8% |
| 118 | Craniopharyngioma | 4.8% |
| 119 | Cystadenoma | 4.8% |
| 120 | leiomyosarcoma | 4.8% |
| 121 | liposarcoma | 4.8% |
| 122 | Mesothelioma | 4.8% |
| 123 | synovial sarcoma | 4.8% |
| 124 | Neuroectodermal Tumor, Melanotic | 4.8% |
| 125 | Angiomyolipoma | 4.8% |
| 126 | Clear Cell Sarcoma of Soft Tissue | 4.8% |
| 127 | Alveolar Soft Part Sarcoma | 4.8% |
| 128 | Neuroendocrine Tumors | 4.8% |
| 129 | Sarcoma, Myeloid | 4.8% |
| 130 | Carcinoma, Basal Cell | 4.8% |
| 131 | Neoplasms, Radiation-Induced | 4.6% |
| 132 | Multiple Endocrine Neoplasia | 4.5% |
| 133 | Glomerulonephritis, Membranoproliferative | 4.4% |
| 134 | Melanoma, Experimental | 4.4% |
| 135 | Adenoma, Acidophil | 4.4% |
| 136 | Ganglioneuroma | 4.4% |
| 137 | Glioma | 4.4% |
| 138 | Malignant Glioma | 4.4% |
| 139 | Sarcoma, Experimental | 4.3% |
| 140 | Splenic Infarction | 4.2% |
| 141 | Histiocytosis, Langerhans-Cell | 4.1% |
| 142 | Endometrial Stromal Sarcoma | 4.1% |
| 143 | Thrombocytopenic purpura | 4% |
| 144 | Cryoglobulinemia | 4% |
| 145 | Leukemia L1210 | 3.8% |
| 146 | Leukemia P388 | 3.8% |
| 147 | Acanthoma | 3.8% |
| 148 | Cystadenocarcinoma | 3.8% |
| 149 | Fibrosarcoma | 3.8% |
| 150 | Osteosarcoma | 3.8% |
| 151 | Mucoepidermoid Carcinoma | 3.8% |
| 152 | Choriocarcinoma | 3.8% |
| 153 | Carcinoma, Lobular | 3.8% |
| 154 | Autoimmune thrombocytopenia | 3.7% |
| 155 | Immune thrombocytopenic purpura | 3.7% |
| 156 | Medulloblastoma | 3.7% |
| 157 | Paraneoplastic Encephalomyelitis | 3.6% |
| 158 | Carcinoid Tumor | 3.6% |
| 159 | Neurilemmoma | 3.6% |
| 160 | Hutchinson's Melanotic Freckle | 3.6% |
| 161 | Melanoma, Amelanotic | 3.6% |
| 162 | Tuberous Sclerosis | 3.5% |
| 163 | Mammary Neoplasms, Experimental | 3.5% |
| 164 | Splenic Rupture | 3.5% |
| 165 | Bone Marrow Neoplasms | 3.5% |
| 166 | Nephroblastoma | 3.5% |
| 167 | POEMS Syndrome | 3.4% |
| 168 | Abdominal Neoplasms | 3.4% |
| 169 | Erythroplasia | 3.4% |
| 170 | Follicular cyst | 3.4% |
| 171 | Head and Neck Neoplasms | 3.4% |
| 172 | Mucocele | 3.4% |
| 173 | Pilonidal Cyst | 3.4% |
| 174 | Soft Tissue Neoplasms | 3.4% |
| 175 | Thoracic Neoplasms | 3.4% |
| 176 | Thyroglossal Cyst | 3.4% |
| 177 | Synovial Cyst | 3.4% |
| 178 | Aberrant Crypt Foci | 3.4% |
| 179 | Disseminated Intravascular Coagulation | 3.4% |
| 180 | Protein S Deficiency | 3.4% |
| 181 | Lymphopenia | 3.4% |
| 182 | Transfusion-Related Acute Lung Injury | 3.4% |
| 183 | Anemia | 3.3% |
| 184 | Blood Coagulation Disorders | 3.3% |
| 185 | Blood Platelet Disorders | 3.3% |
| 186 | Bone Marrow Diseases | 3.3% |
| 187 | Hemorrhagic Disorders | 3.3% |
| 188 | Immune Complex Diseases | 3.3% |
| 189 | Leukocyte Disorders | 3.3% |
| 190 | Methemoglobinemia | 3.3% |
| 191 | Pancytopenia | 3.3% |
| 192 | Polycythemia | 3.3% |
| 193 | Sulfhemoglobinemia | 3.3% |
| 194 | Antiphospholipid Syndrome | 3.3% |
| 195 | Thrombophilia | 3.3% |
| 196 | Latex allergy | 3.3% |
| 197 | Erythrocytosis | 3.3% |
| 198 | Adenofibroma | 3.3% |
| 199 | Fibroadenoma | 3.3% |
| 200 | Malignant Fibrous Histiocytoma | 3.3% |
| 201 | Mastocytosis | 3.2% |
| 202 | Leukemia, Myelomonocytic, Chronic | 3.1% |
| 203 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.1% |
| 204 | Retinoblastoma | 3.1% |
| 205 | Adenocarcinoma | 3% |
| 206 | Carcinoma in Situ | 3% |
| 207 | Carcinoma, Transitional Cell | 3% |
| 208 | Phyllodes Tumor | 3% |
| 209 | Dysgerminoma | 3% |
| 210 | Hemangioendothelioma | 3% |
| 211 | Lipoma | 3% |
| 212 | Myoma | 3% |
| 213 | Myxoma | 3% |
| 214 | Neuroma | 3% |
| 215 | Papilloma | 3% |
| 216 | Pseudomyxoma Peritonei | 3% |
| 217 | Seminoma | 3% |
| 218 | Papillomatosis | 3% |
| 219 | Angiolipoma | 3% |
| 220 | Myelolipoma | 3% |
| 221 | Neoplasms, Bone Tissue | 3% |
| 222 | Neoplasms, Fibrous Tissue | 3% |
| 223 | Smooth Muscle Tumor | 3% |
| 224 | Adenomatosis, Pulmonary | 3% |
| 225 | Adenomatous Polyps | 3% |
| 226 | Carcinoma, Large Cell | 3% |
| 227 | Carcinoma, Small Cell | 3% |
| 228 | Desmoplastic Small Round Cell Tumor | 3% |
| 229 | Chondroma | 3% |
| 230 | Enchondroma | 3% |
| 231 | Digestive System Neoplasms | 2.9% |
| 232 | Endocrine Gland Neoplasms | 2.9% |
| 233 | Eye Neoplasms | 2.9% |
| 234 | Nervous System Neoplasms | 2.9% |
| 235 | Sarcoma 180 | 2.9% |
| 236 | Bowen's Disease | 2.8% |
| 237 | Paraganglioma | 2.8% |
| 238 | Rhabdomyosarcoma | 2.8% |
| 239 | Giant Cell Tumor of Bone | 2.8% |
| 240 | Bone neoplasms | 2.8% |
| 241 | Leukoplakia | 2.8% |
| 242 | Pancreatic Cyst | 2.8% |
| 243 | Skin Neoplasms | 2.8% |
| 244 | Environmental Illness | 2.8% |
| 245 | Barrett Esophagus | 2.8% |
| 246 | Breast Cyst | 2.8% |
| 247 | Actinic keratosis | 2.8% |
| 248 | Mediastinal Cyst | 2.8% |
| 249 | Neoplasm Invasiveness | 2.8% |
| 250 | Neoplasm Metastasis | 2.8% |
| 251 | Neoplasm Recurrence, Local | 2.8% |
| 252 | Parovarian Cyst | 2.8% |
| 253 | Pericardial Cyst | 2.8% |
| 254 | Thymic Cyst | 2.8% |
| 255 | Carcinogenesis | 2.8% |
| 256 | Myxoid cyst | 2.8% |
| 257 | Metastasis | 2.8% |
| 258 | Astrocytoma | 2.8% |
| 259 | Ependymoma | 2.8% |
| 260 | oligodendroglioma | 2.8% |
| 261 | Ganglioglioma | 2.8% |
| 262 | gliosarcoma | 2.8% |
| 263 | Anaplastic astrocytoma | 2.8% |
| 264 | Anaplastic Oligodendroglioma | 2.8% |
| 265 | Thrombocythemia, Essential | 2.8% |
| 266 | Lupus Erythematosus, Systemic | 2.7% |
| 267 | Pregnancy Complications, Hematologic | 2.7% |
| 268 | Overlap syndrome | 2.7% |
| 269 | Addison Disease | 2.7% |
| 270 | Pemphigus | 2.7% |
| 271 | Autoimmune thyroiditis | 2.7% |
| 272 | Primary Adrenal Insufficiency | 2.7% |
| 273 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.7% |
| 274 | Autoimmune hepatitis | 2.7% |
| 275 | Lymphohistiocytosis, Hemophagocytic | 2.7% |
| 276 | Schnitzler Syndrome | 2.7% |
| 277 | Erdheim-Chester Disease | 2.7% |
| 278 | Mesoblastic Nephroma | 2.7% |
| 279 | Hemangioma, Cavernous | 2.6% |
| 280 | Basal Cell Nevus Syndrome | 2.6% |
| 281 | Thrombasthenia | 2.5% |
| 282 | Antithrombin III Deficiency | 2.5% |
| 283 | Protein C Deficiency | 2.5% |
| 284 | Neurofibrosarcoma | 2.4% |
| 285 | Dermatofibrosarcoma | 2.4% |
| 286 | Dermatofibrosarcoma Protuberans | 2.4% |
| 287 | Malignant Carcinoid Syndrome | 2.4% |
| 288 | Multiple Endocrine Neoplasia Type 1 | 2.3% |
| 289 | Hepatocellular Adenoma | 2.3% |
| 290 | Corpus Luteum Cyst | 2.3% |
| 291 | Ovarian Cysts | 2.3% |
| 292 | Kernicterus | 2.3% |
| 293 | Vitamin K Deficiency | 2.3% |
| 294 | Latent Autoimmune Diabetes in Adults | 2.3% |
| 295 | Dermatitis Herpetiformis | 2.2% |
| 296 | Kounis Syndrome | 2.2% |
| 297 | Liver Neoplasms, Experimental | 2.2% |
| 298 | HIV Infections | 2.2% |
| 299 | Hydrops Fetalis | 2.2% |
| 300 | Wiskott-Aldrich Syndrome | 2.2% |
| 301 | Mastocytosis, Systemic | 2.1% |
| 302 | Parathyroid Neoplasms | 2.1% |
| 303 | Peritoneal Neoplasms | 2.1% |
| 304 | Thyroid Neoplasm | 2.1% |
| 305 | Thyroid carcinoma | 2.1% |
| 306 | Polycythemia Vera | 2.1% |
| 307 | Thrombocytosis | 2.1% |
| 308 | Job Syndrome | 2.1% |
| 309 | Lambert-Eaton Myasthenic Syndrome | 2% |
| 310 | Sturge-Weber Syndrome | 2% |
| 311 | Afibrinogenemia | 2% |
| 312 | Factor VII Deficiency | 2% |
| 313 | Factor X Deficiency | 2% |
| 314 | Factor XII Deficiency | 2% |
| 315 | Hemophilia A | 2% |
| 316 | Activated Protein C Resistance | 2% |
| 317 | Factor II deficiency | 2% |
| 318 | Factor VIII Deficiency | 2% |
| 319 | Factor V deficiency | 2% |
| 320 | Factor XI Deficiency | 2% |
| 321 | Hypoprothrombinemias | 2% |
| 322 | Carcinoma, Pancreatic Ductal | 2% |
| 323 | Gastrointestinal Stromal Tumors | 2% |
| 324 | Choledochal Cyst | 2% |
| 325 | Prolactinoma | 2% |
| 326 | Growth Hormone-Secreting Pituitary Adenoma | 2% |
| 327 | neurofibroma | 2% |
| 328 | Peutz-Jeghers Syndrome | 2% |
| 329 | Glioblastoma | 2% |
| 330 | Neuroblastoma | 2% |
| 331 | Glioblastoma Multiforme | 2% |
| 332 | Rheumatoid Arthritis | 2% |
| 333 | Juvenile arthritis | 2% |
| 334 | Graves Disease | 1.9% |
| 335 | Anti-Glomerular Basement Membrane Disease | 1.9% |
| 336 | Pheochromocytoma | 1.9% |
| 337 | Alveolar rhabdomyosarcoma | 1.9% |
| 338 | Pancreatic Neoplasm | 1.9% |
| 339 | Adenomatous Polyposis Coli | 1.9% |
| 340 | Hydatidiform Mole | 1.8% |
| 341 | Eosinophilic Granuloma | 1.8% |
| 342 | Leukemia, Myeloid, Chronic-Phase | 1.8% |
| 343 | Splenosis | 1.8% |
| 344 | Retroperitoneal Neoplasms | 1.8% |
| 345 | granulosa cell tumor | 1.8% |
| 346 | Carcinoma, Ovarian Epithelial | 1.8% |
| 347 | Adenoid Cystic Carcinoma | 1.8% |
| 348 | fibroma | 1.8% |
| 349 | Fibromatosis | 1.8% |
| 350 | Osteoblastoma | 1.8% |
| 351 | Osteoma | 1.8% |
| 352 | Rhabdomyoma | 1.8% |
| 353 | Chondromatosis | 1.8% |
| 354 | Adenocarcinoma, Clear Cell | 1.8% |
| 355 | Cholangiocarcinoma | 1.8% |
| 356 | Cervical Intraepithelial Neoplasia | 1.8% |
| 357 | Hemangioblastoma | 1.8% |
| 358 | Acoustic Neuroma | 1.7% |
| 359 | Chronic granulomatous disease | 1.7% |
| 360 | Asthma, Aspirin-Induced | 1.7% |
| 361 | anaphylaxis | 1.7% |
| 362 | Anemia, Hemolytic | 1.7% |
| 363 | Anemia, Macrocytic | 1.7% |
| 364 | Eosinophilia | 1.7% |
| 365 | Food Allergy | 1.7% |
| 366 | Hypoproteinemia | 1.7% |
| 367 | Leukopenia | 1.7% |
| 368 | Thrombocytopenia | 1.7% |
| 369 | Leukostasis | 1.7% |
| 370 | MYELODYSPLASTIC SYNDROME | 1.7% |
| 371 | Anaphylactic shock | 1.7% |
| 372 | Tracheal Neoplasms | 1.6% |
| 373 | Leukoplakia, Oral | 1.6% |
| 374 | Paraneoplastic Cerebellar Degeneration | 1.6% |
| 375 | Optic Nerve Glioma | 1.6% |
| 376 | Ganglioneuroblastoma | 1.6% |
| 377 | Carcinoid Heart Disease | 1.5% |
| 378 | Serum Sickness | 1.5% |
| 379 | Mouth Neoplasms | 1.5% |
| 380 | Central Nervous System Neoplasms | 1.5% |
| 381 | Vascular Neoplasms | 1.5% |
| 382 | Genital Neoplasms, Female | 1.4% |
| 383 | Pancreatic Pseudocyst | 1.4% |
| 384 | Lymphatic Metastasis | 1.4% |
| 385 | Neoplasms, Unknown Primary | 1.4% |
| 386 | Leukemic Infiltration | 1.4% |
| 387 | Breast Neoplasms, Male | 1.4% |
| 388 | Neoplasm Micrometastasis | 1.4% |
| 389 | Triple Negative Breast Neoplasms | 1.4% |
| 390 | Mastocytoma | 1.4% |
| 391 | Vipoma | 1.4% |
| 392 | Hemoglobinuria, Paroxysmal | 1.4% |
| 393 | Leukemoid Reaction | 1.4% |
| 394 | Respiratory Hypersensitivity | 1.4% |
| 395 | Esophageal Neoplasms | 1.4% |
| 396 | Limbic Encephalitis | 1.4% |
| 397 | Anemia, Neonatal | 1.4% |
| 398 | Leukocytosis | 1.4% |
| 399 | Pelger-Huet Anomaly | 1.4% |
| 400 | Sick Building Syndrome | 1.4% |
| 401 | Pleocytosis | 1.4% |
| 402 | Multiple Chemical Sensitivity | 1.4% |
| 403 | Denys-Drash Syndrome | 1.4% |
| 404 | Urticaria | 1.4% |
| 405 | Vasculitis, Leukocytoclastic, Cutaneous | 1.4% |
| 406 | Myelitis, Transverse | 1.4% |
| 407 | Ataxia Telangiectasia | 1.4% |
| 408 | HTLV-I Infections | 1.4% |
| 409 | Nasopharyngeal carcinoma | 1.4% |
| 410 | insulinoma | 1.3% |
| 411 | Testicular Neoplasms | 1.3% |
| 412 | Xeroderma Pigmentosum | 1.3% |
| 413 | Anemia, Sickle Cell | 1.3% |
| 414 | Thalassemia | 1.3% |
| 415 | Purpura, Thrombotic Thrombocytopenic | 1.2% |
| 416 | Adrenal Gland Neoplasms | 1.2% |
| 417 | Gastrointestinal Neoplasms | 1.2% |
| 418 | Genital Neoplasms, Male | 1.2% |
| 419 | Liver neoplasms | 1.2% |
| 420 | Uveal Neoplasms | 1.2% |
| 421 | Urologic Neoplasms | 1.2% |
| 422 | Sebaceous Gland Neoplasms | 1.2% |
| 423 | Spinal Neoplasms | 1.2% |
| 424 | Polycystic Ovary Syndrome | 1.2% |
| 425 | Adrenocortical carcinoma | 1.2% |
| 426 | Fibromatosis, Aggressive | 1.2% |
| 427 | Fibromatosis, Abdominal | 1.2% |
| 428 | Klatskin Tumor | 1.2% |
| 429 | Myasthenia Gravis | 1.2% |
| 430 | Uveomeningoencephalitic Syndrome | 1.2% |
| 431 | Thyroid Nodule | 1.1% |
| 432 | Opsoclonus-Myoclonus Syndrome | 1.1% |
| 433 | Drug Eruptions | 1.1% |
| 434 | Ecchymosis | 1.1% |
| 435 | Petechiae | 1.1% |
| 436 | Purpura | 1.1% |
| 437 | Granulomatosis with polyangiitis | 1.1% |
| 438 | Dermatitis, Allergic Contact | 1.1% |
| 439 | HIV Seropositivity | 1.1% |
| 440 | Leydig Cell Tumor | 1.1% |
| 441 | Anemia, Diamond-Blackfan | 1.1% |
| 442 | Gastrinoma | 1.1% |
| 443 | Glucagonoma | 1.1% |
| 444 | Renal Cell Carcinoma | 1.1% |
| 445 | Papillary Renal Cell Carcinoma | 1.1% |
| 446 | Stiff-Person Syndrome | 1% |
| 447 | Polyradiculoneuropathy | 1% |
| 448 | Polyradiculoneuritis | 1% |
| 449 | Acquired Immunodeficiency Syndrome | 1% |
| 450 | AIDS related complex | 1% |
| 451 | Felty Syndrome | 1% |
| 452 | Lupus Nephritis | 1% |
| 453 | Carcinoma, Endometrioid | 1% |
| 454 | ovarian neoplasm | 0.9% |
| 455 | Purpura, Hyperglobulinemic | 0.9% |
| 456 | Primary Myelofibrosis | 0.9% |
| 457 | Agranulocytosis | 0.9% |
| 458 | Anemia, Megaloblastic | 0.9% |
| 459 | Lymphocytosis | 0.9% |
| 460 | Myelofibrosis | 0.9% |
| 461 | Myeloid Metaplasia | 0.9% |
| 462 | Milk Allergy | 0.9% |
| 463 | Hypoalbuminemia | 0.9% |
| 464 | Wheat Hypersensitivity | 0.9% |
| 465 | Hypereosinophilic syndrome | 0.9% |
| 466 | bone marrow fibrosis | 0.9% |
| 467 | Thrombotic Microangiopathies | 0.9% |
| 468 | AIDS-Related Opportunistic Infections | 0.9% |
| 469 | Vasculitis, Central Nervous System | 0.9% |
| 470 | Waterhouse-Friderichsen Syndrome | 0.9% |
| 471 | Dermatitis, Atopic | 0.9% |
| 472 | HIV Wasting Syndrome | 0.9% |
| 473 | Rheumatoid Vasculitis | 0.9% |
| 474 | AIDS Dementia Complex | 0.9% |
| 475 | AIDS-Associated Nephropathy | 0.9% |
| 476 | Nose Neoplasms | 0.8% |
| 477 | Dupuytren Contracture | 0.8% |
| 478 | Myasthenia Gravis, Autoimmune, Experimental | 0.8% |
| 479 | Meningeal Neoplasms | 0.8% |
| 480 | Urticaria Pigmentosa | 0.8% |
| 481 | Hemolytic-Uremic Syndrome | 0.8% |
| 482 | Pituitary Adenoma | 0.8% |
| 483 | Pituitary Neoplasms | 0.8% |
| 484 | Sicca Syndrome | 0.8% |
| 485 | Sjogren's Syndrome | 0.8% |
| 486 | HIV-Associated Lipodystrophy Syndrome | 0.8% |
| 487 | Lupus Vasculitis, Central Nervous System | 0.7% |
| 488 | Zollinger-Ellison syndrome | 0.7% |
| 489 | Palatal Neoplasms | 0.7% |
| 490 | Ear Neoplasms | 0.7% |
| 491 | Eyelid Neoplasms | 0.7% |
| 492 | Lung Neoplasms | 0.7% |
| 493 | Pleural Neoplasms | 0.7% |
| 494 | Sickle Cell Trait | 0.7% |
| 495 | Cell Transformation, Viral | 0.7% |
| 496 | Brain Neoplasms | 0.7% |
| 497 | Salivary Gland Neoplasms | 0.7% |
| 498 | Spinal Cord Neoplasms | 0.7% |
| 499 | Tongue Neoplasms | 0.7% |
| 500 | Uterine Neoplasms | 0.7% |
| 501 | Vaginal Neoplasms | 0.7% |
| 502 | Vulvar Neoplasms | 0.7% |
| 503 | Uterine Cancer | 0.7% |
| 504 | Fallopian Tube Neoplasms | 0.7% |
| 505 | Eosinophilia-Myalgia Syndrome | 0.6% |
| 506 | Angioedema | 0.6% |
| 507 | Multiple Sclerosis | 0.6% |
| 508 | Shwartzman Phenomenon | 0.6% |
| 509 | Scurvy | 0.6% |
| 510 | Purpura Fulminans | 0.6% |
| 511 | Acute Generalized Exanthematous Pustulosis | 0.6% |
| 512 | Pharyngeal Neoplasms | 0.6% |
| 513 | Central Nervous System Cysts | 0.6% |
| 514 | Bile Duct Neoplasms | 0.6% |
| 515 | gallbladder neoplasm | 0.6% |
| 516 | Intestinal Neoplasms | 0.6% |
| 517 | Penile Neoplasms | 0.6% |
| 518 | Prostatic Neoplasms | 0.6% |
| 519 | Stomach Neoplasms | 0.6% |
| 520 | Fanconi Anemia | 0.6% |
| 521 | Acute Chest Syndrome | 0.5% |
| 522 | Asthma | 0.5% |
| 523 | Laryngeal neoplasm | 0.5% |
| 524 | Encephalomyelitis, Acute Disseminated | 0.5% |
| 525 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.5% |
| 526 | Erythema Nodosum | 0.5% |
| 527 | Neuritis, Autoimmune, Experimental | 0.5% |
| 528 | Neuromyelitis Optica | 0.5% |
| 529 | Dermatitis, Photoallergic | 0.5% |
| 530 | Leukoencephalitis, Acute Hemorrhagic | 0.5% |
| 531 | Bladder Neoplasm | 0.5% |
| 532 | Kidney Neoplasm | 0.5% |
| 533 | Ureteral Neoplasms | 0.5% |
| 534 | Urethral Neoplasms | 0.5% |
| 535 | Neutropenia | 0.5% |
| 536 | Meningeal Carcinomatosis | 0.5% |
| 537 | Aspergillosis, Allergic Bronchopulmonary | 0.5% |
| 538 | Guillain-Barre Syndrome | 0.5% |
| 539 | Niemann-Pick Disease, Type C | 0.5% |
| 540 | Atypical Hemolytic Uremic Syndrome | 0.5% |
| 541 | Bronchial Neoplasms | 0.4% |
| 542 | Pulmonary Eosinophilia | 0.4% |
| 543 | Eosinophilic Pneumonia | 0.4% |
| 544 | Toxic Epidermal Necrolysis | 0.4% |
| 545 | Stevens-Johnson Syndrome | 0.4% |
| 546 | Multiple Pulmonary Nodules | 0.4% |
| 547 | Supratentorial Neoplasms | 0.4% |
| 548 | Endometrial Neoplasms | 0.4% |
| 549 | Anemia, Pernicious | 0.4% |
| 550 | Pseudoxanthoma Elasticum | 0.4% |
| 551 | Giant Cell Arteritis | 0.4% |
| 552 | Temporal Arteritis | 0.4% |
| 553 | Hypopharyngeal Neoplasms | 0.3% |
| 554 | Pleural Effusion, Malignant | 0.3% |
| 555 | Hypopharyngeal Cancer | 0.3% |
| 556 | Parotid Neoplasms | 0.3% |
| 557 | Prostatic Neoplasms, Castration-Resistant | 0.3% |
| 558 | Nelson Syndrome | 0.3% |
| 559 | Asthma, Exercise-Induced | 0.3% |
| 560 | Status Asthmaticus | 0.3% |
| 561 | Multiple Sclerosis, Chronic Progressive | 0.3% |
| 562 | Multiple Sclerosis, Relapsing-Remitting | 0.3% |
| 563 | Cecal Neoplasms | 0.3% |
| 564 | Duodenal Neoplasms | 0.3% |
| 565 | Asthma, Occupational | 0.3% |
| 566 | Febrile Neutropenia | 0.3% |
| 567 | Farmer's Lung | 0.3% |
| 568 | Angioedemas, Hereditary | 0.3% |
| 569 | Hay fever | 0.3% |
| 570 | Rhinitis, Allergic, Perennial | 0.3% |
| 571 | Nasopharyngeal Neoplasms | 0.3% |
| 572 | Colorectal Neoplasms | 0.3% |
| 573 | Brain Stem Neoplasms | 0.3% |
| 574 | Paranasal Sinus Neoplasms | 0.2% |
| 575 | Tonsillar Neoplasms | 0.2% |
| 576 | Cerebellar Neoplasms | 0.2% |
| 577 | Radicular Cyst | 0.2% |
| 578 | Appendiceal Neoplasms | 0.2% |
| 579 | Colonic Neoplasms | 0.2% |
| 580 | Rectal Neoplasms | 0.2% |
| 581 | Hereditary Angioedema Type III | 0.2% |
| 582 | Hereditary Angioedema Types I and II | 0.2% |
| 583 | Choroid Plexus Papilloma | 0.2% |
| 584 | Miller Fisher Syndrome | 0.2% |
| 585 | Maxillary Sinus Neoplasms | 0.2% |
| 586 | Anus Neoplasms | 0.1% |
| 587 | Sigmoid Neoplasms | 0.1% |
